RRG001 Clinical Trials
2 recruitingDrug
Early Phase 11Phase 11Phase 21
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Safety and Efficacy of RRG001 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)
Neovascular Age-related Macular Degeneration
Shanghai Refreshgene Technology Co., Ltd.48 enrolled1 locationNCT06141460
Recruiting
Early Phase 1
The Preliminary Safety and Efficacy of RRG001 After Vitrectomy in Subjects With Proliferative Diabetic Retinopathy (PDR)
PDR - Proliferative Diabetic Retinopathy
Li Xiaorong6 enrolled1 locationNCT06412224